A Prospective Randomised Trial Comparing Temozolomide With PCV In The Treatment Of Recurrent WHO Astrocytic Tumours Grades III And IV.

Trial Profile

A Prospective Randomised Trial Comparing Temozolomide With PCV In The Treatment Of Recurrent WHO Astrocytic Tumours Grades III And IV.

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Temozolomide (Primary) ; Lomustine; Procarbazine; Vincristine
  • Indications Anaplastic astrocytoma; Glioblastoma; Glioma; Gliosarcoma
  • Focus Therapeutic Use
  • Acronyms BR12
  • Most Recent Events

    • 30 Sep 2011 United Kingdom Clinical Research Network reports status avtive, no loger recruiting.
    • 12 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ISRCTN: Current Controlled Trials.
    • 12 Nov 2010 Planned End Date changed from 1 Apr 2009 to 31 Jan 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top